Tolnaftate 10 MG/ML Topical Solution [Fungi-Nail Reformulated Mar 2019] — RxCUI 2120579
RxNorm drug concept · Semantic branded drug
RxCUI 2120579
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2120579
Official nameTolnaftate 10 MG/ML Topical Solution [Fungi-Nail Reformulated Mar 2019]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asFungi-Nail Reformulated Mar 2019 1 % Topical Solution; Fungi-Nail Reformulated Mar 2019 10 MG/ML Topical Solution
FDA products mapped1
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tolnaftate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on what you're treating. For athlete's foot and ringworm, plan on using it daily for about 4 weeks. For jock itch, 2 weeks is the usual course. Some products mention you...
- How long does it take for tolnaftate to work?
- Tolnaftate is not effective for treating infections on the scalp or on the nails themselves — most products say so right on the label. Some liquid and patch products are designed t...
- Stop applying the product and let your doctor know. A little initial sensitivity can happen, but worsening irritation is a sign that you should get it checked out. Don't push throu...
🕸️ Concept Web — How Tolnaftate 10 MG/ML Topical Solution [Fungi-Nail... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tolnaftate 10 MG/ML Topical Solution [Fungi-Nail Reformulated Mar 2019]
RxCUI 2120579 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tolnaftate
10637IN
-
Tolnaftate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Fungi-Nail Reformulated Mar 2019
2120575BN
-
Fungi-Nail Reformulated Mar 2019
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tolnaftate Topical Solution
374159SCDF -
Tolnaftate Topical Product
1157650SCDG -
Tolnaftate Topical Solution [Fungi-Nail Reformulated Mar 2019]
2120577SBDF -
Fungi-Nail Reformulated Mar 2019 Topical Product
2120578SBDG -
Topical Solution
316986DF -
Topical Product
1151122DFG
-
Tolnaftate Topical Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tolnaftate 10 MG/ML Topical Solution
313423SCD -
Tolnaftate 10 MG/ML
328892SCDC -
Tolnaftate 10 MG/ML [Fungi-Nail Reformulated Mar 2019]
2120576SBDC
-
Tolnaftate 10 MG/ML Topical Solution
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tolnaftate 10 MG/ML Topical Solution
SCD · 313423 -
Tolnaftate 10 MG/ML
SCDC · 328892 -
Tolnaftate Topical Solution
SCDF · 374159 -
Tolnaftate Topical Product
SCDG · 1157650
Brand-Name Concepts
-
Tolnaftate 10 MG/ML [Fungi-Nail Reformulated Mar 2019]
SBDC · 2120576 -
Tolnaftate Topical Solution [Fungi-Nail Reformulated Mar 2019]
SBDF · 2120577 -
Fungi-Nail Reformulated Mar 2019 Topical Product
SBDG · 2120578 -
Fungi-Nail Reformulated Mar 2019
BN · 2120575
📦 FDA Products & Package NDCs
1 product · 4 package NDCs
4 package NDCs map to RxCUI 2120579 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 55505-0177-24 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (55505-177-24) / 15 m... | Fungi Nail Toe and Foot | Kramer Laboratories | 2025-04-01 |
| 55505-0177-26 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (55505-177-26) / 30 m... | Fungi Nail Toe and Foot | Kramer Laboratories | 2019-03-25 |
| 55505-0177-80 | 1 BOTTLE, SPRAY in 1 CARTON (55505-177-80) / 30 mL in 1 BOT... | Fungi Nail Toe and Foot | Kramer Laboratories | 2022-12-10 |
| 55505-0177-87 | 2 CARTON in 1 PACKAGE (55505-177-87) / 1 BOTTLE, WITH APPLI... | Fungi Nail Toe and Foot | Kramer Laboratories | 2019-12-27 |
Observed labelers:
Kramer Laboratories (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.